Fosnetupitant Chloride Hydrochloride

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 2 records

Fosnetupitant Chloride Hydrochloride 2 markets · 2 records Forms
Filters
MarketAU 1SG 1
Kind

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 260 mg per mL / per unit basis not statedinjection CombinationFosnetupitant Chloride Hydrochloride 260 mg + Palonosetron Hydrochloride 0.28 mgAKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial unknown

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 235 mg/vial per mL / per unit basis not statedinjection CombinationFosnetupitant Chloride Hydrochloride 235 mg/vial + Palonosetron 0.25 mg/vialAkynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.